The Clinical Significance of Combined Application of Matrix Metalloproteinase -3 and Anti-Cyclic Citrullinated Peptide Antibody in the Diagnosis and Treatment of Rheumatoid Arthritis

WANG Lu, LI Hanhua, WENG Wenhao, ZHANG Min, ZHAO Meiyun, CAI Huiping, LU Tianyu

PDF(1320 KB)
Welcome to Labeled Immunoassays and Clinical Medicine website!
PDF(1320 KB)
Labeled Immunoassays and Clinical Medicine ›› 2022, Vol. 29 ›› Issue (4) : 580-583. DOI: 10.11748/bjmy.issn.1006-1703.2022.04.009
Clinical Investigation

The Clinical Significance of Combined Application of Matrix Metalloproteinase -3 and Anti-Cyclic Citrullinated Peptide Antibody in the Diagnosis and Treatment of Rheumatoid Arthritis

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 29(4): 580-583 https://doi.org/10.11748/bjmy.issn.1006-1703.2022.04.009

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1320 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备18063657号-2
Copyright © Labeled Immunoassays and Clinical Medicine, All Rights Reserved.
Tel: 010-68515701,68517801　E-mail: bjmy@circ.com.cn

/

〈 〉